Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$26.4 - $32.56 $22,070 - $27,220
-836 Reduced 8.75%
8,716 $235,000
Q3 2023

Nov 14, 2023

BUY
$27.17 - $31.97 $13,367 - $15,729
492 Added 5.43%
9,552 $267,000
Q2 2023

Aug 10, 2023

BUY
$28.34 - $33.63 $7,085 - $8,407
250 Added 2.84%
9,060 $283,000
Q1 2023

May 15, 2023

BUY
$25.31 - $29.02 $222,981 - $255,666
8,810 New
8,810 $248,000
Q4 2022

Jun 14, 2023

BUY
$21.94 - $26.24 $32,273 - $38,599
1,471 Added 16.7%
10,281 $269 Million
Q3 2022

Jun 14, 2023

BUY
$22.0 - $31.87 $22,396 - $32,443
1,018 Added 11.56%
9,828 $219 Million
Q2 2022

Jun 20, 2023

BUY
$26.4 - $30.54 $26,875 - $31,089
1,018 Added 11.56%
9,828 $293 Million
Q1 2022

Jun 20, 2023

BUY
$23.07 - $27.99 $23,485 - $28,493
1,018 Added 11.56%
9,828 $259 Million
Q4 2021

Jun 21, 2023

BUY
$21.47 - $32.08 $715,530 - $1.07 Million
33,327 Added 378.29%
42,137 $980 Million
Q3 2021

Jun 21, 2023

BUY
$23.37 - $32.13 $778,851 - $1.07 Million
33,327 Added 378.29%
42,137 $1.3 Billion
Q2 2021

Jun 21, 2023

BUY
$18.78 - $25.15 $660,868 - $885,028
35,190 Added 399.43%
44,000 $1.08 Billion
Q1 2021

Jun 26, 2023

SELL
$18.21 - $23.2 $102,230 - $130,244
-5,614 Reduced 63.72%
3,196 $59.7 Million
Q4 2020

Jun 22, 2023

SELL
$15.39 - $22.1 $88,307 - $126,809
-5,738 Reduced 65.13%
3,072 $61.3 Million
Q3 2020

Jun 26, 2023

SELL
$16.16 - $20.66 $91,174 - $116,563
-5,642 Reduced 64.04%
3,168 $52.5 Million
Q2 2020

Jun 26, 2023

SELL
$13.31 - $19.41 $74,496 - $108,637
-5,597 Reduced 63.53%
3,213 $62.3 Million
Q1 2020

Jul 12, 2023

SELL
$13.06 - $21.24 $65,678 - $106,815
-5,029 Reduced 57.08%
3,781 $54.5 Million
Q4 2019

Jul 12, 2023

SELL
$17.29 - $21.74 $86,951 - $109,330
-5,029 Reduced 57.08%
3,781 $77.1 Million
Q3 2019

Jul 12, 2023

SELL
$19.51 - $24.28 $98,369 - $122,419
-5,042 Reduced 57.23%
3,768 $73.5 Million
Q2 2019

Jul 12, 2023

BUY
$21.47 - $37.33 $54,254 - $94,332
2,527 Added 28.68%
11,337 $256 Million
Q1 2019

Jul 13, 2023

BUY
$28.4 - $36.49 $79,207 - $101,770
2,789 Added 31.66%
11,599 $423 Million
Q4 2018

Jul 13, 2023

BUY
$27.94 - $44.61 $84,686 - $135,212
3,031 Added 34.4%
11,841 $349 Million
Q3 2018

Jul 13, 2023

BUY
$38.6 - $46.12 $118,502 - $141,588
3,070 Added 34.85%
11,880 $504 Million
Q3 2018

Nov 14, 2018

SELL
$38.6 - $46.12 $467,677 - $558,789
-12,116 Closed
0 $0
Q2 2018

Aug 15, 2018

BUY
$40.56 - $51.36 $29,771 - $37,698
734 Added 6.45%
12,116 $0
Q1 2018

May 15, 2018

BUY
$53.61 - $67.26 $160 - $201
3 Added 0.03%
11,382 $0
Q4 2017

Feb 15, 2018

SELL
$47.69 - $55.39 $5,102 - $5,926
-107 Reduced 0.93%
11,379 $623,000
Q3 2017

Nov 14, 2017

BUY
$49.16 - $54.45 $28,807 - $31,907
586 Added 5.38%
11,486 $584,000
Q2 2017

Aug 14, 2017

BUY
N/A
10,900
10,900 $632,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.